Evidence map›Paper›PMID 32406850›Full record

ArticleJournal of medical Internet research2020

Artificial Intelligence and Health Technology Assessment: Anticipating a New Level of Complexity.

Hassane Alami, Pascale Lehoux, Yannick Auclair, Michèle de Guise, Marie-Pierre Gagnon, James Shaw, Denis Roy, Richard Fleet, Mohamed Ali Ag Ahmed, Jean-Paul Fortin

Abstract read
In one paragraph

Article in Journal of medical Internet research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. A life-cycle approach to digital health technology assessment.International journal of technology assessment in health care · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Hassane AlamiPublic Health Research Center, Université de Montréal, Montreal, QC, Canada.ORCID 0000-0002-5461-7693
Pascale LehouxPublic Health Research Center, Université de Montréal, Montreal, QC, Canada.ORCID 0000-0001-9482-1800
Yannick AuclairInstitut national d'excellence en santé et services sociaux, Montréal, QC, Canada.ORCID 0000-0001-8256-0148
Michèle de GuiseInstitut national d'excellence en santé et services sociaux, Montréal, QC, Canada.ORCID 0000-0002-3597-2542
Marie-Pierre GagnonResearch Center on Healthcare and Services in Primary Care, Université Laval, Quebec, QC, Canada.ORCID 0000-0002-0782-5457
James ShawJoint Centre for Bioethics, University of Toronto, Toronto, ON, Canada.ORCID 0000-0002-9522-0756
Denis RoyInstitut national d'excellence en santé et services sociaux, Montréal, QC, Canada.ORCID 0000-0001-5966-2066
Richard FleetResearch Center on Healthcare and Services in Primary Care, Université Laval, Quebec, QC, Canada.ORCID 0000-0003-2732-7655
Mohamed Ali Ag AhmedResearch Chair on Chronic Diseases in Primary Care, Université de Sherbrooke, Chicoutimi, QC, Canada.ORCID 0000-0001-9374-871X
Jean-Paul FortinResearch Center on Healthcare and Services in Primary Care, Université Laval, Quebec, QC, Canada.ORCID 0000-0002-4107-9937

Funding

CIHR
6 · The paper itself

Abstract

Artificial intelligence (AI) is seen as a strategic lever to improve access, quality, and efficiency of care and services and to build learning and value-based health systems. Many studies have examined the technical performance of AI within an experimental context. These studies provide limited insights into the issues that its use in a real-world context of care and services raises. To help decision makers address these issues in a systemic and holistic manner, this viewpoint paper relies on the health technology assessment core model to contrast the expectations of the health sector toward the use of AI with the risks that should be mitigated for its responsible deployment. The analysis adopts the perspective of payers (ie, health system organizations and agencies) because of their central role in regulating, financing, and reimbursing novel technologies. This paper suggests that AI-based systems should be seen as a health system transformation lever, rather than a discrete set of technological devices. Their use could bring significant changes and impacts at several levels: technological, clinical, human and cognitive (patient and clinician), professional and organizational, economic, legal, and ethical. The assessment of AI's value proposition should thus go beyond technical performance and cost logic by performing a holistic analysis of its value in a real-world context of care and services. To guide AI development, generate knowledge, and draw lessons that can be translated into action, the right political, regulatory, organizational, clinical, and technological conditions for innovation should be created as a first step.

Indexed as

Artificial IntelligenceBiomedical TechnologyHumansTechnology Assessment, Biomedicalartificial intelligenceeHealthhealth carehealth serviceshealth technology assessmentmedical devicepatient

Identifiers

PMID32406850
PMCPMC7380986

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.